EXICURE, INC. Employee-related Liabilities, Current
EXICURE, INC. (XCUR) had Employee-related Liabilities, Current of $94.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Employee-related Liabilities, Current $94.00K.
- 2026-03-31: Employee-related Liabilities, Current $94.00K.
- 2025-12-31: Employee-related Liabilities, Current $82.00K.
- 2025-09-30: Employee-related Liabilities, Current $80.00K.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $94.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $94.00K 10-Q · filed 2026-05-29 |
| 2025-12-31 | $82.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $80.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $17.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $40.00K 10-Q · filed 2025-06-27 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $43.00K 10-Q · filed 2024-06-17 |
| 2023-12-31 | $71.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $43.00K 10-Q · filed 2024-05-16 |
| 2023-06-30 | $16.00K 10-Q/A · filed 2024-06-06 |
| 2023-03-31 | $184.00K 10-Q/A · filed 2024-06-06 |
| 2022-12-31 | $32.00K 10-Q/A · filed 2024-06-06 |
| 2021-12-31 | $167.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $1.13M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $662.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.16M 10-K · filed 2022-03-25 |
| 2020-09-30 | $921.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $706.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $386.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $920.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $781.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $573.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $388.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $899.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $732.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $539.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $329.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $718.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | $513.00K 10-Q · filed 2017-11-14 |
| 2016-12-31 | $423.00K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |